Mark J. Ehlert
Direttore/Membro del Consiglio presso BioQ Pharma, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Mitchell Barneck | M | - |
Light Line Medical, Inc.
 Light Line Medical, Inc. Medical SpecialtiesHealth Technology Light Line Medical, Inc. is a medical company based in an undisclosed location. Light Line Medical has developed a patented, non-invasive visible light platform to prevent catheter-associated infections. The technology uses safe visible light emitted through a fiber optic cable to disinfect and protect the inside and outside of the catheter, killing microbes and preventing infection without relying on drugs, chemicals, or harmful UV light. The American company's published international patent portfolio includes 23 issued patents and 16 pending patent applications. The technology is effective in preventing infections in dialysis, urinary/Foley, respiratory/endotracheal, and vascular catheter use. The company was founded by Mitchell Barneck and has been led by CEO Vicki E. Farrar since 2017. | - |
| Joshua Wilker Kriesel | M | - |
BioQ Pharma, Inc.
 BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | - |
| Vicki E. Farrar | F | - |
Light Line Medical, Inc.
Light Line Medical, Inc. Medical SpecialtiesHealth Technology Light Line Medical, Inc. is a medical company based in an undisclosed location. Light Line Medical has developed a patented, non-invasive visible light platform to prevent catheter-associated infections. The technology uses safe visible light emitted through a fiber optic cable to disinfect and protect the inside and outside of the catheter, killing microbes and preventing infection without relying on drugs, chemicals, or harmful UV light. The American company's published international patent portfolio includes 23 issued patents and 16 pending patent applications. The technology is effective in preventing infections in dialysis, urinary/Foley, respiratory/endotracheal, and vascular catheter use. The company was founded by Mitchell Barneck and has been led by CEO Vicki E. Farrar since 2017. | 7 anni |
| Dinesh C. Patel | M | 73 |
Light Line Medical, Inc.
Light Line Medical, Inc. Medical SpecialtiesHealth Technology Light Line Medical, Inc. is a medical company based in an undisclosed location. Light Line Medical has developed a patented, non-invasive visible light platform to prevent catheter-associated infections. The technology uses safe visible light emitted through a fiber optic cable to disinfect and protect the inside and outside of the catheter, killing microbes and preventing infection without relying on drugs, chemicals, or harmful UV light. The American company's published international patent portfolio includes 23 issued patents and 16 pending patent applications. The technology is effective in preventing infections in dialysis, urinary/Foley, respiratory/endotracheal, and vascular catheter use. The company was founded by Mitchell Barneck and has been led by CEO Vicki E. Farrar since 2017. | - |
| Llew Keltner | M | 74 |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | - |
| Ronald E. Pauli | M | 63 |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | - |
| Agnes Le Saux-Narjoz | F | - |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | 10 anni |
| Norvall Jasper | M | 77 |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | - |
| Daniel Tassé | M | 64 |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | - |
| Richard Nesbit | M | - |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | - |
| Viscount Christopher Portman | M | - |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | - |
| Christopher Vega | M | - |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | 12 anni |
| Ralph McNall | M | - |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | 11 anni |
| Kelly Powers | M | - |
Light Line Medical, Inc.
Light Line Medical, Inc. Medical SpecialtiesHealth Technology Light Line Medical, Inc. is a medical company based in an undisclosed location. Light Line Medical has developed a patented, non-invasive visible light platform to prevent catheter-associated infections. The technology uses safe visible light emitted through a fiber optic cable to disinfect and protect the inside and outside of the catheter, killing microbes and preventing infection without relying on drugs, chemicals, or harmful UV light. The American company's published international patent portfolio includes 23 issued patents and 16 pending patent applications. The technology is effective in preventing infections in dialysis, urinary/Foley, respiratory/endotracheal, and vascular catheter use. The company was founded by Mitchell Barneck and has been led by CEO Vicki E. Farrar since 2017. | - |
| Greg Fredde | M | - |
Light Line Medical, Inc.
Light Line Medical, Inc. Medical SpecialtiesHealth Technology Light Line Medical, Inc. is a medical company based in an undisclosed location. Light Line Medical has developed a patented, non-invasive visible light platform to prevent catheter-associated infections. The technology uses safe visible light emitted through a fiber optic cable to disinfect and protect the inside and outside of the catheter, killing microbes and preventing infection without relying on drugs, chemicals, or harmful UV light. The American company's published international patent portfolio includes 23 issued patents and 16 pending patent applications. The technology is effective in preventing infections in dialysis, urinary/Foley, respiratory/endotracheal, and vascular catheter use. The company was founded by Mitchell Barneck and has been led by CEO Vicki E. Farrar since 2017. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 15 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Mark J. Ehlert
- Contatti personali
